REG - TP ICAP Group PLC - Result of External Audit Tender

TP IcapAnnouncement

28/07/2022 17:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220728:nRSb1577Ua&default-theme=true

RNS Number : 1577U  TP ICAP Group PLC  28 July 2022

TP ICAP Group plc

LEI: 2138006YAA7IRVKKGE63

28 July 2022

 

TP ICAP Proposes Appointment of PwC as External Auditor from 2024

TP ICAP Group plc (the 'Company' or 'TP ICAP') today announces that the Board
has approved the proposed appointment of PricewaterhouseCoopers LLP ('PwC') as
its new external auditor, following the conclusion of a competitive tender
process led by the Company's Audit Committee. The appointment will be subject
to approval by shareholders at the 2024 Annual General Meeting and, if
approved, will take effect for the financial year ending 31 December 2024. The
tender process has been carried out in line with Competition and Markets
Authority regulations, applicable EU requirements and Financial Reporting
Council guidance.

 

Subject to the reappointment by shareholders at the 2023 Annual General
Meeting, the incumbent auditors Deloitte LLP ('Deloitte') will continue in
their role until the year ending 31 December 2023. On completion of the 2023
audit, they will stand down having reached the maximum duration of audit
engagement. A thorough transition process will be undertaken to ensure an
effective handover from Deloitte to PwC.

 

There are no matters in relation to Deloitte's forthcoming retirement as the
Company's external auditor to be brought to the attention of shareholders.

 

For further information, please contact:

 

Enquiries:

 

Dominic Lagan

Head of Investor Relations

Direct: +44 (0) 20 3933 3040

Email: Dominic.Lagan@tpicap.com (mailto:Dominic.Lagan@tpicap.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPPUGPMUPPGQR